Rapid and cytocompatible cell-laden silk hydrogel formation via riboflavin-mediated crosslinking
Source abstract
Abstract
Bioactive hydrogels based on naturally-derived polymers are of great interest for regenerative medicine applications. Among naturally-derived polymers, silk fibroin has been extensively explored as a biomaterial for tissue engineering due to its unique mechanical properties. Here, we demonstrate the rapid gelation of cell-laden silk fibroin hydrogels by visible light-induced crosslinking using riboflavin as a photo-initiator, in presence of an electron acceptor. The gelation kinetics were monitored by in situ photo-rheometry. Gelation was achieved in minutes and could be tuned owing to its direct proportionality to the electron acceptor concentration. The concentration of the electron acceptor did not affect the elastic modulus of the hydrogels, which could be altered by varying the polymer content. Further, the biocompatible riboflavin photo-initiator combined with sodium persulfate allowed for the encapsulation of cells within silk fibroin hydrogels. To confirm the cytocompatibility of the silk fibroin formulations, three cell types (articular cartilage-derived progenitor cells, mesenchymal stem cells and dental-pulp-derived stem cells) were encapsulated within the hydrogels, which associated with a viability >80% for all cell types. These results demonstrated that fast gelation of silk fibroin can be achieved by combining it with riboflavin and electron acceptors, which results in a hydrogel that can be used in tissue engineering and cell delivery applications.
Source: openalex_inverted_index · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Silk-based biomaterials and applications · Electrospun Nanofibers in Biomedical Applications · RNA Interference and Gene Delivery
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Orthopaedics
University Medical Center Utrecht
Utrecht University
Utrecht
The Netherlands
Department of Developmental BioEngineering
Technical Medical Centre
University of Twente
Enschede
Regenerative Medicine Utrecht
Department of Clinical Sciences
Department of Pharmaceutics
Utrecht Institute for Pharmaceutical Sciences (UIPS)
Science for Life
Funding
ReumaNederland
References (43)
Show source-provided references
1. Tibbitt · Biotechnol. Bioeng. · 2009 · 103 · 65510.1002/bit.22361 ↗
2. Huang · Acta Biomater. · 2019 · 97 · 7410.1016/j.actbio.2019.08.013 ↗
3. Guvendiren · Curr. Opin. Biotechnol · 2013 · 24 · 84110.1016/j.copbio.2013.03.009 ↗
4. Slaughter · Adv. Mater. · 2009 · 21 · 330710.1002/adma.200802106 ↗
5. Jonker · Chem. Mater. · 2012 · 24 · 75910.1021/cm202640w ↗
6. Hasturk · Biomaterials · 2020 · 232 · 11972010.1016/j.biomaterials.2019.119720 ↗
7. Applegate · Adv. Mater. · 2016 · 28 · 241710.1002/adma.201504527 ↗
8. Harkin · Biomaterials · 2011 · 32 · 244510.1016/j.biomaterials.2010.12.041 ↗
9. Chouhan · Adv. Healthcare Mater. · 2018 · 7 · 180109210.1002/adhm.201801092 ↗
10. Shi · Adv. Mater. · 2017 · 29 · 170108910.1002/adma.201701089 ↗
11. Kapoor · Acta Biomater. · 2016 · 31 · 1710.1016/j.actbio.2015.11.034 ↗
12. Holland · Adv. Healthcare Mater. · 2019 · 8 · 180046510.1002/adhm.201800465 ↗
13. Elliott · ACS Appl. Mater. Interfaces · 2015 · 7 · 1209910.1021/acsami.5b02308 ↗
14. Lee · Clin. Exp. Dermatol. · 2012 · 37 · 76210.1111/j.1365-2230.2011.04331.x ↗
15. Das · Acta Biomater. · 2015 · 11 · 23310.1016/j.actbio.2014.09.023 ↗
16. Partlow · Adv. Funct. Mater. · 2014 · 24 · 461510.1002/adfm.201400526 ↗
17. Lee · Biomed. Mater. · 2015 · 11 · 01410110.1088/1748-6041/11/1/014101 ↗
18. Fancy · Proc. Natl. Acad. Sci. U. S. A. · 1999 · 96 · 602010.1073/pnas.96.11.6020 ↗
19. Whittaker · J. Mater. Chem. B · 2014 · 2 · 625910.1039/C4TB00698D ↗
20. Cui · Adv. Healthcare Mater. · 2020 · 9 · 190166710.1002/adhm.201901667 ↗
21. Han Ang · Eur. J. Inorg. Chem. · 2006 · 400310.1002/ejic.200600723 ↗
22. Novakova · Biochemistry · 1995 · 34 · 1236910.1021/bi00038a034 ↗
23. Liu · Adv. Healthcare Mater. · 2018 · 7 · 180095410.1002/adhm.201800954 ↗
24. Camp · Front. Chem. · 2020 · 8 · 17310.3389/fchem.2020.00173 ↗
25. Rockwood · Nat. Protoc. · 2011 · 6 · 161210.1038/nprot.2011.379 ↗
26. Lohmann · Sci. Transl. Med. · 2017 · 9 · eaai904410.1126/scitranslmed.aai9044 ↗
27. Karvinen · Mater. Sci. Eng., C · 2019 · 94 · 105610.1016/j.msec.2018.10.048 ↗
28. Levato · Acta Biomater. · 2017 · 61 · 4110.1016/j.actbio.2017.08.005 ↗
29. Redmond · Photochem. Photobiol. · 2019 · 95 · 109710.1111/php.13126 ↗
30. Placone · Ann. Biomed. Eng. · 2017 · 45 · 23710.1007/s10439-016-1621-7 ↗
31. McCall · Invest. Ophthalmol. Visual Sci. · 2010 · 51 · 12910.1167/iovs.09-3738 ↗
32. McGill · Acta Biomater. · 2017 · 63 · 7610.1016/j.actbio.2017.09.020 ↗
33. Su · ACS Appl. Mater. Interfaces · 2017 · 9 · 1748910.1021/acsami.7b04623 ↗
34. Choi · Adv. Healthcare Mater. · 2019 · 8 · 190064410.1002/adhm.201900644 ↗
35. Wang · J. Mater. Chem. B · 2018 · 6 · 273910.1039/C8TB00607E ↗
36. Peppas · Adv. Mater. · 2006 · 18 · 134510.1002/adma.200501612 ↗
37. Peppas · Eur. J. Pharm. Biopharm. · 2000 · 50 · 2710.1016/S0939-6411(00)00090-4 ↗
38. Kim · Biomacromolecules · 2004 · 5 · 78610.1021/bm0345460 ↗
39. Kang · Macromol. Rapid Commun. · 2000 · 21 · 78810.1002/1521-3927(20000701)21:11<788::AID-MARC788>3.0.CO;2-X ↗
40. McCarthy · Vet. J. · 2012 · 192 · 34510.1016/j.tvjl.2011.08.036 ↗
41. Longoni · Eur. Cells Mater. · 2020 · 39 · 12110.22203/eCM.v039a08 ↗
42. Yao · Spine J. · 2018 · 18 · 107010.1016/j.spinee.2018.02.007 ↗
43. Elvin · Biomaterials · 2010 · 31 · 832310.1016/j.biomaterials.2010.07.032 ↗